EULAR 2020 : TALTZ® (ixékizumab) de Lilly continue de montrer une efficacité robuste et constante dans le traitement du rhumatisme psoriasique

NEXT STORY
Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on June 9, 2020
PREV STORY
ICMYI: Virgin Pulse Kicks Off First THRIVEx Virtual Summit; Highlights Latest Homebase for Health™ Innovations Including VP+ Partner Service, VP Passport Return-to-Workplace Solution, and New Digital Therapeutics for Hypertension, Weight Management and Pre-Diabetes
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy

author_avatar
NASDAQ Market News

Roche to present new and updated data for seven approved and investigational medicines across multiple types of breast cancer at the 2019 San Antonio Breast Cancer Symposium

author_avatar
NASDAQ Market News

ABOG Appoints New Chair and Members of Subspecialty Divisions

New Chair and Members Start on July 1Dallas, Feb. 14, 2019 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News